Martine Clozel

Martine Clozel (born 27 December 1955) is a scientist, entrepreneur and co-founder of Actelion and Idorsia.[1]

Education and career

Clozel studied at the University of Nancy and the University of California in San Francisco. She also attended further training in physiology and pharmacology at McGill University.[2]

In 1997, she founded Actelion with her husband Jean-Paul Clozel.[3][4] The company was sold in 2017 to the American pharmaceutical and consumer products company Johnson & Johnson for US$30 billion.[5] Martine Clozel founded the pharmaceutical company Idorsia in 2017 and has since served as head of research. She is one of the most successful female company founders in Switzerland.[6]

Awards

References
  1. "Idorsia Pharmaceuticals Ltd: Idorsia congratulates its Chief Scientific Officer Martine Clozel who has been honored by". bloomberg.com. 13 November 2022. Retrieved 14 December 2022.
  2. "More entrepreneurship – Courageous transformations". idorsia.com. Retrieved 14 December 2022.
  3. Denise Roland (2 March 2017). "Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm". wsj.com. Retrieved 14 December 2022.
  4. Pascal Züger (13 June 2018). "Das ist die Frau hinter dem Erfolg von Idorsia und Actelion". cash.ch. Retrieved 14 December 2022.
  5. John Miller (26 January 2017). "Medical couple and butcher's boy win big from Actelion sale". reuters.com. Retrieved 14 December 2022.
  6. Karen Merkel-Gyger (22 August 2018). ""Wir wissen genau, wo wir in fünf Jahren sein wollen"". handelszeitung.ch. Retrieved 14 December 2022.
  7. "Idorsia congratulates its Chief Scientific Officer Martine Clozel who has been honored by Initiative Switzerland with the Annual Prix Suisse Award". globenewswire.com. 13 November 2022. Retrieved 14 December 2022.
  8. https://actu.epfl.ch/news/epfl-celebrates-1043-new-master-s-graduates/
  9. Dominik Fischer (13 November 2022). "Martine Clozel geehrt – "sie verändert das Leben von Patienten weltweit"". 20min.ch. Retrieved 14 December 2022.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.